• 2022-2023

    DATE SPEAKER TITLE
    Oct 19, 2022 Tim Mitchison

    How does the microtubule drug colchicine work as a medicine?

    Feb 1, 2023

    Len Zon

    Melanoma Initiation and the Cancer Niche
    Mar 8, 2023 David Matthew Altshuler Humanizing Drug Discovery
    Apr 19, 2023 Bill Kaelin

    Von Hippel-Lindau Disease: Insights into Oxygen Sensing, Protein Degradation, and Cancer

    May 31, 2023 Anna Greka

    Dissecting cargo receptor-mediated membrane protein trafficking in health and disease

  • 2021-2022

    Oct 18, 2021 Chenghua Gu, PhD The Neuro-vascular interactions in the CNS
    Dec 01, 2021 Myles Brown, MD Essential Cancer Genes and Cistromes
    Jan 26, 2022 Sekar Kathiresan, MD From reading the genome for risk to rewriting it for cardiovascular health
    Mar 23, 2022 Joan Brugge, PhD Evolution of Concepts about Oncogenes and Mechanisms of Tumorigenesis
    May 4, 2022 Rosalind Segal, MD, PhD Cancer, chemotherapy and nerves
    Jun 27, 2022 Harald Stenmark, PhD Membrane dynamics and cancer
    Jul 7, 2022 Einat Zalckvar, PhD Peroxisomes - from systematic screens to human diseases
    Jul 19, 2022 Daniel Gerlich Chromosome dynamics during the cell cycle
    Jul 22, 2022 Brenda Schulman Unfolding mysteries of cullin-RING E3 ubiquitin ligases
    Jul 29, 2022 David Komander The activation mechanisms of PINK1 and Parking during mitophagy
  • 2020-2021

    DATE SPEAKER TITLE
    Oct 14, 2020 Michael Gottesman, MD The Complexity and Relevance of Multidrug Resistance in Cancer
    Dec 2, 2020 Don W Cleveland, PhD “Designer DNA drug” therapies for neurodegenerative disease: What’s next?
    Feb 21, 2020 Anthony Letai, MD, PhD Poking mitochondria to choose the right cancer drugs
    Mar 24, 2021 Stephen J Elledge, PhD Spying on the immune system
    May 5, 2021 Barbara B Kahn, MD Mechanisms by which adipose tissue regulates metabolic health and disease
  • 2019-2020

    DATE SPEAKER TITLE
    Nov 6, 2019 Patricia A D'Amore, PhD, MBA VEGF, Angiogenesis and Macular Degeneration
    Dec 11, 2019 David E. Fisher, MD, PhD Lessons for melanoma therapeutics based on its unique pathogenesis
    Feb 12, 2020 Denisa Wagner, PhD Inflammation and thrombosis, if it does not save you, it will kill you
    Apr 1, 2020 Stephen Liberles, PhD Regulation of body functions by the vagus nerve
  • 2018-2019

    DATE SPEAKER TALK TITLE
    Dec 5, 2018 Dennis J Selkoe, MD Cell Biology of Alzheimer’s and Parkinson’s Diseases Reveals New Therapeutic Targets
    Jan 16, 2019 David Sinclair, PhD Advances in reprogramming to turn back the aging clock
    Mar 13, 2019 Morris Birnbaum, MD, PhD Pathophysiology and Therapeutic Strategies for Metabolic Disease
    May 8, 2019 Stuart Orkin, MD Reactivating fetal hemoglobin to treat hemoglobin disorders: genetic and non-genetic approaches
    May 29, 2019 Richard Ransohoff, MD Neuroinflammation: What is it, how does it contribute to neurological disease?
  • 2017-2018

    DATE SPEAKER TALK TITLE
    Nov 2, 2017 George Q Daley, PhD A twenty year quest to derive Hematopoietic Stem Cells in vitro
    Jan 17, 2018 Benjamin Ebert, MD, PhD Therapeutic targeting of ubiquitin ligase activity.
    Mar 7, 2018 Leslie Leinwand, PhD Myosin myopathies: pathogenesis and potential therapies
    Apr 18, 2018 Lee Rubin, PhD Looking at Neurological Disorders from Different Perspectives
    May 30, 2018 Frank Slack, PhD Translating ncRNA discoveries to personalized RNA medicine for cancer
  • 2016-2017

    DATE SPEAKER TALK TITLE
    Nov 16, 2016 Gary Borisy, PhD Mapping the Microbiome at the Micron Scale
    Jan 18, 2017 Junying Yuan, PhD Necroptosis: from basic cell biology to human clinical studies
    Mar 8, 2017 Leonard Zon, MD Pathways regulating hematopoietic stem cell self-renewal and migration
    Apr 12, 2017 Vamsi Mootha, MD Mitochondrial parts, pathways, and pathogenesis
    May 3, 2017 Peter Libby, MD Inflammation in Atherosclerosis - a Translational Journey
  • 2015-2016

    DATE SPEAKER TALK TITLE
    Jan 20, 2016 Richard Gregory, PhD Defective RNA metabolism in childhood developmental syndromes
    Feb 17, 2016 Monty Krieger, PhD Heart Attacks and Strokes: The Cholesterol Connection and Lipoprotein Receptors
    Mar 16, 2016 Isaac Chiu, PhD Neuro-immune interactions in pain and host defense
    Apr 27, 2016 Arlene Sharp, MD, PhD Cancer immunotherapy: The PD-1 pathway from discover to translation
    Jun 1, 2016 Shalender Bhasin, MD Muscle in a Bottle: The Pharmaceutical Applications of Androgen Biology
  • 2014-2015

    DATE SPEAKER TALK TITLE
    Dec 17, 2014 Thomas Schwarz, PhD
    Mar 25, 2015 Richard T. Lee, MD
    Apr 22, 2015 Ulrich von Andrian, MD, PhD Career decisions: How T cells remember pathogens
    May 20, 2015 Kim Lewis, PhD Finding antibiotics to cure chronic infections
  • 2013-2014

    DATE SPEAKER TALK TITLE
    Jan 16, 2013 Charles Serhan, PhD Resolving Inflammation: Elucidation of the Mediators and their Therapeutic Potential
    Mar 20, 2013 David Cohen, MD, PhD START Domain-Mediated Metabolic Regulation Reveals New Therapeutic Targets for Diabetes and Obesity
    Mar 27, 2013 Benjamin Podbilewicz, PhD Membrane Proteins Mediating Cell-Cell Fusion?
    May 15, 2013 Joseph Loscalzo, MD, PhD Redox Dysregulation in Vascular Pathobiology
    Jun 19, 2013 Louis Kunkel, PhD Muscular Dystrophy: From Gene Discovery to Therapy
    Nov 20, 2013 Brad Lowell, MD, PhD The Neural Wiring Diagram for Hunger: Using Cre/Lox Tools to Discover its Basis
    Feb 19, 2014 David Scadden, MD Stem cell niche in homeostasis and cancer
    Mar 19, 2014 David Glass, PhD Molecular causes of skeletal muscle loss and function, and their treatment
    Apr 16, 2014 Phil Kantoff, MD Prostate Cancer, a Disease of Paradoxes
    Jun 18, 2014 Connie Cepko, PhD Strategies to prolong vision in inherited forms of blindness